Abstract
To establish whether somatostatin (SRIH) and/or endogenous opioids play a role in the control of arginine–vasopressin (AVP) response to physical exercise, eight healthy men underwent four bicycle–ergometer tests until exhaustion: exercise control test; exercise plus SRIH, naloxone or SRIH plus naloxone. Serum AVP levels, physiological and biochemical variables were measured during tests. Physiological and biochemical variables were similar in all tests. During control test exercise significantly increased serum AVP levels, with a peak value 4.1 times higher than baseline. The AVP response to exercise was similar in the presence of naloxone, whereas it was significantly reduced by SRIH (AVP peak was only 2.8 times higher than baseline). When SRIH and naloxone were given together, the exercise-induced AVP rise was comparable to that observed in the control test. Results indicate a somatostatinergic involvement in the regulation of the AVP response to physical exercise. Furthermore, naloxone-sensitive endogenous opioids appear to play a role in the mechanism underlying SRIH inhibitory action, but not in mediation of the AVP response to physical exercise.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baylis PH (1983) Posterior pituitary function in health and disease. Clin Endocrinol Metab 12:747–770
Beardwell CG, Geelen G, Palmer HM, Roberts D, Salomonson L (1975) Radioimmunoassay of plasma vasopressin in physiological and pathological states in man. J Endocrinol 67:189–202
Chiodera P, Coiro V (1991) Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycaemia in man. J Neural Transm 83:121–126
Chiodera P, Louis F, Legros JJ (1984) Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE sephadex A25 extraction. J Endocrinol Invest 7:287–293
Coiro V, Chiodera P (1991) Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man. Neuroendocrinology 53:209–213
Convertino VA, Keil LC, Bernauer EM, Greenleaf JE (1981) Plasma volume, osmolality, vasopressin and renin activity during graded exercise in man. J Appl Physiol 50:123–128
Dierick K, Vandesande F (1979) Immunocytochemical localization of somatostatin-containing neurons in the rat hypothalamus. Cell Tiss Res 201:349–359
Lightman SL, Forling ML (1980) Evidence for endogenous opioid control of vasopressin release in man. J Clin Endocrinol Metab 50:569–571
Lightman SL, Langdon N, Forling ML (1980) Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to hypertonic stimulus in man. J Clin Endocrinol Metab 51:1447–1449
Lightman SL, Langdon N, Todd K, Forling ML (1982) Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man. Clin Endocrinol 16:353–358
Maresh CM, Wang BC, Goetz KL (1985) Plasma vasopressin, renal activity, and aldosterone responses to maximal exercise in active college females. Eur J Appl Physiol 54:398–403
Melin B, Eclache JP, Geelen G, Annat G, Alleward AM,Jarsaillon E,Zebidi A, Legros JJ, Gharib CL (1989) Plasma AVP, neurophysin, renin activity and aldosterone during submaximal exercise performed until exhaustion in trained and untrained men. Eur J Appl Physiol 44:141–151
Muller EE (1987) Neural control of somatotropic function. Physiol Rev 67:962–1053
Saavedra JM, Rougeot C, Chevillard C, Dray F (1983) High, vasopressin reversible, immunoreactive somatostatin in specific hypothalamic nuclei of rats with diabetes insipidus (Brattleboro rats). Brain Res 277:23–30
Wade CE, Claybaugh JR (1980) Plasma renin activity, vasopressin concentration and urinary excretory responses to exercise in men. J Appl Physiol 49:930–936
Weindl A, Sofroniew MV (1980) Immunocytochemical localization of hypothalamic peptide hormones in neural target areas. In: Wuttke W, Weindl A, Voigt KM, Dries RR (eds) Brain and pituitary peptides. Karger, Basel, pp 97–109
Wittert GA, Stewart DE, Graves MP, Ellis MJ, Evans MJ, Wells JE, Donald RA Espiner EA (1991) Plasma corticotrophin releasing factor and vasopressin responses to exercise in normal man. Clin Endocrinol 35:311–317
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coiro, V., Casti, A., Rubino, P. et al. Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men. J Neural Transm 115, 803–807 (2008). https://doi.org/10.1007/s00702-008-0026-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-008-0026-7